This website is intended for healthcare professionals only and contains promotional content.

United Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.

Prof. Andrew Davies - the impact of breakthrough pain for people with cancer

Professor Andrew Davies is a Professor of Palliative Medicine at Trinity College Dublin, University College Dublin, and Our Lady's Hospice in Dublin. Here he talks about different types of breakthrough cancer pain and how patients suffer as a result of its impact on their quality of life.

What is the impact of breakthrough pain for patients with cancer?

For advice on the responsible use of opioids to treat pain, including other types of pain, please click here

How useful was this page to you?

Average:

References

1. KKI/INT/KKI/0647 November 2023

Europe

Prof. Andrew Davies - the impact of breakthrough pain for people with cancer

Professor Andrew Davies is a Professor of Palliative Medicine at Trinity College Dublin, University College Dublin, and Our Lady's Hospice in Dublin. Here he talks about different types of breakthrough cancer pain and how patients suffer as a result of its impact on their quality of life.